Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Immunotherapy. 2011 Apr;3(4):517–537. doi: 10.2217/imt.11.10

Table 3.

Selection of current monoclonal therapy clinical trials open to pancreatic cancer patients.

Treatment ClinicalTrials.gov ID
MORAb-009 (anti-mesothelin) NCT01018784, NCT00711191
Trastuzumab (anti-Her2/neu) NCT00003797
Cetuximab (anti-EGFR) NCT00923299, NCT00042939, NCT00448838, NCT00305760, NCT00075686, NCT00408564, NCT00467116
Panitumumab (anti-EGFR) NCT00004879, NCT00601627, NCT00550836
Nimotuzumab (anti-EGFR) NCT00561990
Trastuzumab and cetuximab NCT00599833

EGFR: EGF-receptor.